# RedStroke - Reducing Europe's Stroke Incidence

Study · id `cardio:ct-nct04108884` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04108884](<https://clinicaltrials.gov/study/NCT04108884>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04108884

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems; Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1019 participants.

## Technical summary

Registry record NCT04108884. Randomized; triple masking; primary purpose screening. Start 2019-10-22 (actual); primary completion 2024-01-18 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose screening
- Phase: Not applicable
- Enrolled: 1019 participants (enrolled count; ClinicalTrials.gov record NCT04108884, source copy `cardio:ctgov-nct04108884-2024-05-17`, retrieved 2026-10-26)
- Started: 2019-10-22 (actual) (ClinicalTrials.gov record NCT04108884, source copy `cardio:ctgov-nct04108884-2024-05-17`, retrieved 2026-10-26)
- Primary completion: 2024-01-18 (actual) (ClinicalTrials.gov record NCT04108884, source copy `cardio:ctgov-nct04108884-2024-05-17`, retrieved 2026-10-26)
- Completion: 2024-01-18 (actual) (ClinicalTrials.gov record NCT04108884, source copy `cardio:ctgov-nct04108884-2024-05-17`, retrieved 2026-10-26)
- Countries: Germany; Greece; Hungary; Netherlands; Poland; Switzerland (ClinicalTrials.gov record NCT04108884, source copy `cardio:ctgov-nct04108884-2024-05-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04108884-2024-05-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: RedStroke - Reducing Europe's Stroke Incidence
- Acronym: RedStroke
- Condition: Atrial Fibrillation
- Intervention (Device): App measurement
- Intervention (Device): 14 day Holter ECG
- Lead sponsor: University Hospital, Basel, Switzerland
- Lead sponsor class: OTHER
- Collaborator: European Union
- Collaborator class: OTHER
- Collaborator: Preventicus GmbH
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: University Hospital, Basel, Switzerland (`cardio:org-university-hospital-basel-switzerland`)
- Registry lists this organization as a collaborator: European Union (`cardio:org-european-union`)
- Registry lists this organization as a collaborator: Preventicus GmbH (`cardio:org-preventicus-gmbh`)

## Provenance

Content hash: d0f3c954257a670fa798dc46bb29d537d97d30b7576d7da71b72703ed33abba9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
